Merten
The hunt for neutralising antibodies against SARS-CoV-2
Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could…
Miniature testing of drug pairs on tumour biopsies
Combinations of cancer drugs can be quickly and cheaply tested using a novel microfluidic device…
Synchronised waves control embryonic patterning
EMBL scientists show that the rhythm between Wnt and Notch waves enables patterning in embryos.…
Sorting out HIV
An EMBL collaboration devises a new method that could speed up vaccine development for HIV…
The rhythms in life
How EMBL scientists are discovering and understanding the waves and rhythms inside us…
Sense of space
EMBL scientists demonstrate that spatial constraints are a key factor in determining nucleus size.…
Welcome: Kyung-Min Noh
The important thing is forming good biological questions, says new group leader in Genome Biology.…
